S-C Huang
Overview
Explore the profile of S-C Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsao C, Ting M, Chou N, Chi N, Chen Y, Huang S, et al.
Transplant Proc
. 2018 Nov;
50(9):2751-2755.
PMID: 30401390
Methods: We retrospectively reviewed 5 years of 440 consecutive adult patients (≥ 18 years) who underwent first HTx from June 1987 to December 2014 at the National Taiwan University Hospital....
2.
Ting M, Tsao C, Wang C, Chi N, Huang S, Chou N, et al.
Transplant Proc
. 2018 Nov;
50(9):2747-2750.
PMID: 30401389
Objectives: An oversized cardiac allograft may have a negative impact on survival outcomes according to previous studies; however, due to the shortage of pediatric donor hearts, the use of oversized...
3.
Huang F, Huang S
Benef Microbes
. 2016 Sep;
7(5):739-748.
PMID: 27680208
Salmonella spp. remains a major public health problem for the whole world. Intestinal epithelial cells serve as an essential component of the innate mucosal immune system to defend against Salmonella...
4.
Wang C, Wang T, Wu K, Huang S, Kuo K
Bone Joint J
. 2016 Aug;
98-B(8):1145-50.
PMID: 27482031
Aims: This study compared the long-term results following Salter osteotomy and Pemberton acetabuloplasty in children with developmental dysplasia of the hip (DDH). We assessed if there was a greater increase...
5.
Tsao C, Chou N, Chi N, Huang S, Tsan C, Wang C, et al.
Transplant Proc
. 2016 May;
48(3):978-81.
PMID: 27234783
Background: Transplantation and immunosuppressive drugs are major limitations to the success of pregnancy. In 1988, the first pregnancy after a heart transplant was reported, which has given female recipients the...
6.
Wang Y, Chi N, Chou N, Huang S, Wang C, Wu I, et al.
Transplant Proc
. 2016 May;
48(3):974-7.
PMID: 27234782
Background: Malignancy is the leading cause of death in Taiwan. The risk of malignancy is higher in heart transplant recipients than in the general population. We reviewed the malignancy incidence...
7.
Wang Y, Chi N, Chou N, Huang S, Wang C, Wu I, et al.
Transplant Proc
. 2016 May;
48(3):969-73.
PMID: 27234781
Background: With advances in immunosuppressive therapy, heart transplantation is currently recommended as the only established surgical treatment for refractory heart failure. However, chronic immunosuppression increases the risk for malignancy. Everolimus...
8.
Lin S, Huang S, Chen Y, Chih N, Wang C, Chou N, et al.
Transplant Proc
. 2016 May;
48(3):959-64.
PMID: 27234779
Background: Fontan failure (FF) occurs rarely. In patients with Fontan failure, heart transplantation is believed to be the most effective therapy. We review our experience in heart transplantations after the...
9.
Ting M, Wang C, Tsao C, Huang S, Chi N, Chou N, et al.
Transplant Proc
. 2016 May;
48(3):951-5.
PMID: 27234777
Background: Acute fulminant myocarditis with intractable cardiogenic shock is a fatal condition; its only therapeutic option is mechanical circulatory support. The use of mechanical circulatory support, either extracorporeal membrane oxygenation...
10.
Cheng A, Sheng W, Huang Y, Sun H, Tsai Y, Chen M, et al.
Clin Microbiol Infect
. 2016 Jan;
22(4):382.e1-382.e11.
PMID: 26794030
Postprocedural infections by Mycobacterium abscessus complex are increasing worldwide, and the source and route of transmission are infrequently identified. Here the extension of a previous clustering of paediatric patients with...